UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054125
Receipt number R000061805
Scientific Title Investigation of the significance of combining cone-beam CT-guided ultrathin bronchoscopic forceps biopsy with needle biopsy for peripheral pulmonary lesions.
Date of disclosure of the study information 2024/04/12
Last modified on 2024/04/11 21:01:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the significance of combining cone-beam CT-guided ultrathin bronchoscopic forceps biopsy with needle biopsy for peripheral pulmonary lesions.

Acronym

Cone-beam CT-guided ultrafine bronchoscopic needle biopsy.

Scientific Title

Investigation of the significance of combining cone-beam CT-guided ultrathin bronchoscopic forceps biopsy with needle biopsy for peripheral pulmonary lesions.

Scientific Title:Acronym

Cone-beam CT-guided ultrathin bronchoscopic needle biopsy.

Region

Japan


Condition

Condition

pulmonary nodular lesion

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To demonstrate the improved diagnostic yield of using cone-beam CT-guided ultra thin bronchoscopy and ultrasound in combination, plus needle biopsy in addition to forceps biopsy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Compare diagnostic yields with forceps biopsy with those with subsequent needle biopsy and forceps biopsy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Forceps biopsy followed by needle biopsy and forceps biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) 18 years of age or older.
2) Patients who are able to obtain their own consent.
3) Patients with a mass or nodule of 30 mm or less in length in the lung field on thin-section CT, suspected lung cancer and requiring bronchoscopy for its diagnosis.

Key exclusion criteria

1) Patients with serious complications
2) Patients with bleeding tendency.
3) Patients allergic to local anaesthetics or sedatives.
4) Pregnant women.
5) Other patients who are expected to have difficulty in performing the study.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Noaya
Middle name
Last name Kawakita

Organization

Institute of Biomedical Sciences, The University of Tokushima Graduate School

Division name

Department of Thoracic and Endocrine Surgery and Oncology

Zip code

770-8503

Address

3-18-15, Kuramoto-cho, Tokushima , Japan

TEL

0886337143

Email

kawakita.naoya@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Naoya
Middle name
Last name Kawakita

Organization

Institute of Biomedical Sciences, The University of Tokushima Graduate School

Division name

Department of Thoracic and Endocrine Surgery and Oncology

Zip code

770-8503

Address

3-18-15, Kuramoto-cho, Tokushima , Japan

TEL

0886337143

Homepage URL


Email

kawakita.naoya@tokushima-u.ac.jp


Sponsor or person

Institute

The University of Tokushima Graduate School

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Tokushima University Hospital

Address

3-18-15, Kuramoto-cho, Tokushima , Japan

Tel

088-633-851

Email

first-ec@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 04 Month 12 Day

Date of IRB


Anticipated trial start date

2024 Year 06 Month 01 Day

Last follow-up date

2028 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 11 Day

Last modified on

2024 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061805


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name